Canopy Growth Corp (TSE:WEED - Get Free Report) shares hit a new 52-week low during trading on Wednesday. The stock traded as low as C$1.03 and last traded at C$1.04, with a volume of 555,289 shares trading hands. The stock had previously closed at C$1.08.
Wall Street Analysts Forecast Growth
Separately, Alliance Global Partners reduced their target price on Canopy Growth from C$1.80 to C$1.60 in a report on Tuesday, June 16th. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of C$1.88.
View Our Latest Report on Canopy Growth
Canopy Growth Stock Down 5.6%
The company has a quick ratio of 2.32, a current ratio of 3.04 and a debt-to-equity ratio of 40.27. The company's fifty day moving average is C$1.33 and its 200-day moving average is C$1.39. The company has a market cap of C$431.50 million, a PE ratio of -1.52, a PEG ratio of -0.01 and a beta of 2.41.
Canopy Growth (TSE:WEED - Get Free Report) last posted its earnings results on Friday, August 7th. The company reported C($0.03) EPS for the quarter. The company had revenue of C$81.17 million during the quarter. Canopy Growth had a negative return on equity of 29.85% and a negative net margin of 73.95%. On average, analysts predict that Canopy Growth Corp will post -0.69 EPS for the current year.
Insider Activity at Canopy Growth
In related news, Director David Angelo Lazzarato sold 22,380 shares of Canopy Growth stock in a transaction on Monday, September 28th. The stock was sold at an average price of C$1.29, for a total value of C$28,870.20. Following the completion of the sale, the director owned 108,237 shares of the company's stock, valued at C$139,625.73. The trade was a 17.13% decrease in their ownership of the stock. Insiders sold a total of 43,492 shares of company stock valued at $56,105 over the last three months. Insiders own 0.21% of the company's stock.
About Canopy Growth
(
Get Free Report)
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Canopy Growth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.
While Canopy Growth currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.